Dime Community Bank Selects Quantifind to Strengthen Sanctions Screening in Payments
Faced with increasing regulatory scrutiny and growing complexity in global transactions, Dime sought a more precise and scalable solution to strengthen its compliance program while maintaining efficient operations. After a competitive evaluation, Dime selected Quantifind for its advanced capabilities in risk detection and seamless integration into existing workflows.
"Our partnership with Quantifind represents a significant advancement in our compliance capabilities," said Michael Fegan, CTO, Dime Community Bank. "Quantifind's AI-driven platform equips us to protect our customers and communities while maintaining the highest standards of regulatory compliance."
"We're proud to partner with Dime Community Bank and extend our support to mid-market banks that are critical to the financial ecosystem," said Graham Bailey, Quantifind COO. "Quantifind's solutions are designed to empower banks of all sizes to tackle financial crime with unparalleled speed, accuracy, and scalability."
Quantifind's commitment to supporting mid-market banks reflects a broader mission to deliver purpose-built AI solutions that help institutions of all sizes detect and mitigate financial crime risks.
About Dime Community Bank
Dime Community Bank, headquartered in Hauppauge, New York, has served its community since 1864. With over 60 locations across the New York metropolitan area, which includes the five boroughs, Long Island, and Westchester County, Dime offers a comprehensive range of financial services for individuals and businesses.
About Quantifind
Quantifind is a leader in financial crime intelligence automation. Its Graphyte™ platform delivers real-time, accurate risk assessments by integrating internal data with unstructured public information, enabling organizations to uncover hidden threats and strengthen compliance with speed, accuracy, and scale.
¹ Aggregate deposit market share for Kings, Queens, Nassau & Suffolk counties for community banks with less than $20 billion in assets.
Forward-Looking Statements
Statements contained in this news release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those currently anticipated.
Media Contact
Annalisa Camarillo
EVP of Marketing, Quantifind
Email: [email protected]
SOURCE Quantifind
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Cision Canada
13 hours ago
- Cision Canada
Breakthrough GameChange Solar Terrain Following System Dramatically Reduces Grading
--Genius Tracker TF ™ now accommodates up to 1.7° post-to-post, enabling the industry's lowest grading requirement on challenging terrain-- NORWALK, Conn., July 1, 2025 /CNW/ -- GameChange Solar, a global leader in solar tracker and fixed-tilt racking systems, announced the next generation of Genius Tracker TF ™, its terrain-following solar tracker. Genius Tracker TF now features exceptional slope adaptability of up to 1.7 degrees between posts. This upgrade allows solar developers to unlock more project sites with difficult topography and dramatically reduce grading costs and environmental impacts by reducing or eliminating grading. "Terrain challenges can be a big barrier to developing utility-scale solar projects," said Derick Botha, Chief Commercial Officer at GameChange Solar. "Genius Tracker TF helps our customers overcome those challenges by offering a tracker solution that works to reduce or eliminate grading by working with the contours of the land." Genius Tracker TF ™ is engineered to conform to natural land contours, eliminating the need for costly grading or complex articulating joints. Its streamlined design boosts profitability by reducing civil work, shortening construction timelines, and minimizing disruptions from elevated work zones. Proven on diverse terrain, TF delivers safe, high-yield performance while supporting faster, more efficient installations on even the most challenging sites. About GameChange Solar GameChange is one of the top three global providers of solar tracker solutions used in utility-scale and ground-mounted distributed generation solar projects around the world. We have delivered over 43 GW of solar tracker and fixed tilt systems that combine fast installation, bankable quality, and unbeatable value through superior engineering, innovative design, and high-volume manufacturing. Our products enable solar panels at power plants to follow the sun's movement across the sky and optimize plant performance while protecting the array from damaging weather conditions. For more information, visit
Cision Canada
13 hours ago
- Cision Canada
TraceLink's MINT Named "Supply Chain Transparency Solution of the Year" in 2025 SupplyTech Breakthrough Awards
The award recognizes MINT for enabling real-time, end-to-end visibility across critical supply chain transactions and processes BOSTON, July 1, 2025 /CNW/ -- TraceLink, the largest end-to-end digital network platform for intelligent supply chain orchestration, today announced that its Multienterprise Information Network Tower (MINT) solution has been named "Supply Chain Transparency Solution of the Year" in the 2025 SupplyTech Breakthrough Awards. The award recognizes MINT for advancing digital transformation in supply chain operations and enabling fully digitalized, integrated, and agile supply chains worldwide. MINT digitalizes global supply chains using TraceLink's proven network and its powerful B2N Integrate-Once™ capability to orchestrate end-to-end business transactions across commerce, direct supply, external manufacturing, logistics, transportation, and other complex multienterprise processes. Using pre-built integrations with leading procurement and supply chain hubs such as GHX and Ariba, MINT rapidly accelerates customers' time-to-value by radically reducing integration complexity. Powered by the industry's only no-code Orchestration Platform for Universal Solutions (OPUS), MINT enables a fundamental shift towards process and partner visibility while creating the continuously-flowing, real-time network data required for GenAI transformation. "Supply chains are subject to a wide range of dynamic challenges that demand reliable, sustainable, and metadata-driven network orchestration solutions," said Shabbir Dahod, President and CEO of TraceLink. "With MINT, we're offering scalable and affordable integration and data exchange across 100% of our customers' end-to-end trade partner network, including biopharmaceutical and medical device manufacturers, pharmacies, hospitals, wholesalers, 3PLs, CMOs, and materials suppliers. It is only through an end-to-end approach that measurable business outcomes like increased agility, improved operational efficiency, and ultimately, enhanced patient safety can be delivered." MINT's winning approach to network integration is simple: to participate, no customer or trading partner needs to change, modify, or retire their existing enterprise system or process. Through the use of TraceLink's proven B2N Integrate-Once ™ universal integration capability, companies exchange data in any desired format (e.g., EDI [ANSI X12, EDIFACT], SAP IDoc, CSV, etc.), using any preferred method of data exchange, including B2B [AS2, SFTP, SMTP, HTTPS], API, email, or UI. This flexibility is even further enhanced through OPUS Link Actions and transforms, which companies leverage as pre-built connectors with many ERP systems such as NetSuite and Microsoft Dynamics. By enabling all companies to participate on the network using their existing tools and capabilities, TraceLink empowers customers to build their own GenAI-ready foundation for intelligent supply chain agents. With MINT, organizations gain actionable insights that improve revenue predictability, optimize inventory, and drive agile, resilient growth. The SupplyTech Breakthrough Awards, conducted annually by Tech Breakthrough, honor the top technology companies, solutions, and products across the global supply chain industry. The program aims to highlight the most innovative and impactful advancements in supply chain technology and services. TraceLink continues to set the standard for leadership and innovation in supply chain orchestration. To learn more about TraceLink and its solutions, please visit: About TraceLink TraceLink Inc. is the largest end-to-end intelligent supply chain platform for life sciences and healthcare, enabling end-to-end orchestration by connecting more than 291,000 healthcare and life sciences entities through its B2N Integrate-Once™ network. Leading businesses trust TraceLink to deliver complete global connectivity, visibility, and traceability of healthcare products, ensuring that every patient gets the medicines they need when needed, safely and securely. To learn more, visit
Cision Canada
14 hours ago
- Cision Canada
Seegene Launches STAgora™, a New Platform for Infectious Disease Analytics
SEOUL, South Korea, July 1, 2025 /CNW/ -- Seegene Inc., a global leader in molecular diagnostics (MDx) solutions, announced today the launch of STAgora™, a next-generation platform for infectious disease analytics. Designed as a real-time infectious disease intelligence system, the platform combines diagnostic data with advanced statistical modeling and aims to redefine how the world detects, tracks, and responds to outbreaks. STAgora™ provides real-time global visualization of infectious disease trends at the municipal, national, and continental levels, based on actual diagnostic test results. The platform delivers healthcare professionals immediate, structured diagnostic reports and statistical analyses in clear, actionable formats. These are supported by customizable dashboards and real-time alert functions. In addition to tracking individual cases, STAgora™ enables users to monitor outbreaks across selected regions, both local and international. This capability provides real-time visibility into disease spread, enhancing situational awareness and supporting timely, data-driven public health responses. By equipping national and global health authorities with real-time epidemiological insight, the platform is expected to strengthen decision-making and support the development of effective response strategies to mitigate large-scale infectious disease outbreaks. With more than 40 built-in statistical tools, STAgora™ enables early detection of abnormal pathogen patterns and supports predictive modeling for seasonal trends and emerging outbreaks. These tools include modules for tracking individual infections, analyzing symptom-based co-infections and calculating real-time infection rate trends. Together, they help transform static data into forward-looking intelligence that guides proactive interventions. Unlike traditional outbreak monitoring systems that rely on retrospective data, STAgora™ performs real-time analysis of PCR-derived diagnostics. This allows for immediate visibility into pathogen spread and, through AI-based algorithms, the forecasting of potential future outbreaks. "The key differentiator of STAgora™ is its unique architecture, which aggregates real-time diagnostic data from around the world into a unified analysis platform," said Young-Seag Baeg, head of strategic planning at Seegene. When paired with Seegene's proprietary syndromic quantitative PCR technology, STAgora™ offers expanded visibility into both single-pathogen infections and simultaneous multi-pathogen co-infections. This comprehensive diagnostic insight empowers clinicians to make faster, more informed decisions at the point of care. "During the COVID-19 pandemic, we saw firsthand how crucial accurate and timely interpretation of diagnostic data was in shaping public health policies and clinical outcomes," said Daniel Shin, executive vice president and chief global sales and marketing officer at Seegene. "Now, as we confront increasingly complex threats such as antimicrobial resistance, viral mutations and co-infections, the ability to deliver actionable insights from diagnostic data is becoming a cornerstone of clinical innovation and a vital pillar of global health security." Seegene will officially debut STAgora™ at the 2025 Association for Diagnostics & Laboratory Medicine (ADLM) annual meeting, taking place July 27 to 31 in Chicago, USA. The event will highlight key capabilities of the platform, including its integration with CURECA™, Seegene's fully automated, unmanned PCR system. ADLM 2025 will also serve as a launchpad for Seegene to explore global collaboration and partnerships with healthcare leaders and clients. With the launch of STAgora™, Seegene aims to lay the foundation for a smarter, faster and more connected global health defense system. By combining real-time molecular diagnostics, AI-driven analytics and global data integration, STAgora™ represents a strategic step toward building an intelligent public health infrastructure capable of responding proactively to emerging threats. The company envisions the platform as a core pillar of the global infectious disease response framework, marking a new step toward enhanced diagnostic insight and preparedness. About Seegene Seegene has more than 20 years of dedicated experience in R&D, manufacturing, and business related to syndromic real-time PCR technologies. This expertise was particularly highlighted during the COVID-19 pandemic when Seegene provided over 340 million COVID-19 tests to more than 100 countries worldwide. The core feature of Seegene's syndromic real-time PCR technology is the ability to simultaneously test for 14 pathogens that cause similar signs and symptoms in a single tube with quantitative information. CURECA™(Continuous, Unlimited, Random-access, Expandable, and Customizable Automation) is a fully automated and modular PCR system that eliminates manual processes and enables continuous, real-time testing. It is a unified platform designed to operate continuously, 24 hours a day, with no human intervention. The very core feature is CPS which is the first part of CURECA™, the world's first automated pre-treatment system capable of handling a full spectrum of specimen types, including blood, stool, sputum, and urine. Designed to support both centralized and decentralized labs, CURECA offers scalable automation and flexible adoption—making it especially valuable in settings with limited space or personnel.
